These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 19327866

  • 1. A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer.
    Bria E, Milella M, Sperduti I, Alessandrini G, Visca P, Corzani F, Giannarelli D, Cerasoli V, Cuppone F, Cecere FL, Marchetti A, Sacco R, Mucilli F, Malatesta S, Guetti L, Vitale L, Ceribelli A, Rinaldi M, Terzoli E, Cognetti F, Facciolo F.
    Lung Cancer; 2009 Dec; 66(3):365-71. PubMed ID: 19327866
    [Abstract] [Full Text] [Related]

  • 2. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y, Sun BS, Zhang ZF, Zhang LM, Wang CL.
    Zhonghua Yi Xue Za Zhi; 2011 Jun 28; 91(24):1682-6. PubMed ID: 21914316
    [Abstract] [Full Text] [Related]

  • 3. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
    Lee JG, Lee CY, Park IK, Kim DJ, Park SY, Kim KD, Chung KY.
    Ann Thorac Surg; 2008 Jan 28; 85(1):211-5. PubMed ID: 18154813
    [Abstract] [Full Text] [Related]

  • 4. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV, Havrilesky LJ, Cragun JM, Secord AA, Calingaert B, Berchuck A, Clarke-Pearson DL, Soper JT.
    Gynecol Oncol; 2006 Jul 28; 102(1):92-7. PubMed ID: 16406063
    [Abstract] [Full Text] [Related]

  • 5. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
    Guan Y, Xu BH, Li Q, Zhang P, Zhao LM, Yuan P, Wang JY.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 08; 88(2):77-81. PubMed ID: 18353207
    [Abstract] [Full Text] [Related]

  • 6. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.
    Rossi CR, Mocellin S, Pasquali S, Pilati P, Nitti D.
    Ann Surg Oncol; 2008 Jan 08; 15(1):310-5. PubMed ID: 17987346
    [Abstract] [Full Text] [Related]

  • 7. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.
    Varlotto JM, Recht A, Nikolov M, Flickinger JC, Decamp MM.
    Cancer; 2009 Feb 15; 115(4):851-8. PubMed ID: 19140203
    [Abstract] [Full Text] [Related]

  • 8. Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study.
    Fernando HC, Sasatomi E, Christie NA, Buenaventura PO, Finkelstein SD, Yousem SA, Soose R, Close JM, Luketich JD.
    J Thorac Cardiovasc Surg; 2004 Jan 15; 127(1):87-91. PubMed ID: 14752417
    [Abstract] [Full Text] [Related]

  • 9. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period.
    Rosenberg R, Friederichs J, Schuster T, Gertler R, Maak M, Becker K, Grebner A, Ulm K, Höfler H, Nekarda H, Siewert JR.
    Ann Surg; 2008 Dec 15; 248(6):968-78. PubMed ID: 19092341
    [Abstract] [Full Text] [Related]

  • 10. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.
    Breast Cancer Res Treat; 2008 Jun 15; 109(3):405-16. PubMed ID: 17687650
    [Abstract] [Full Text] [Related]

  • 11. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
    Zhang GQ, Han F, Gao SL, A DL, Pang ZL.
    Ai Zheng; 2007 May 15; 26(5):519-23. PubMed ID: 17672944
    [Abstract] [Full Text] [Related]

  • 12. A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.
    Yanagisawa K, Tomida S, Shimada Y, Yatabe Y, Mitsudomi T, Takahashi T.
    J Natl Cancer Inst; 2007 Jun 06; 99(11):858-67. PubMed ID: 17551146
    [Abstract] [Full Text] [Related]

  • 13. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J, Muley T, Hoffmann H, Bülzebruck H, Dienemann H.
    Dtsch Med Wochenschr; 2006 Nov 24; 131(47):2643-8. PubMed ID: 17109272
    [Abstract] [Full Text] [Related]

  • 14. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N.
    Gynecol Oncol; 2005 Mar 24; 96(3):651-7. PubMed ID: 15721407
    [Abstract] [Full Text] [Related]

  • 15. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L, Anusca A, Ortega-Deballon P, Cheynel N, Bernard A, Favre JP.
    Eur J Surg Oncol; 2006 Jun 24; 32(5):583-7. PubMed ID: 16621424
    [Abstract] [Full Text] [Related]

  • 16. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
    Bria E, Visca P, Novelli F, Casini B, Diodoro MG, Perrone-Donnorso R, Botti C, Sperduti I, Facciolo F, Milella M, Cecere FL, Cognetti F, Mottolese M.
    Eur J Surg Oncol; 2008 May 24; 34(5):593-8. PubMed ID: 17693049
    [Abstract] [Full Text] [Related]

  • 17. [Impact of different mediastinal lymphadenectomy on clinical-stage IA non-small cell lung cancer].
    Ma K, Wang TY, He BL, Chang D, Gong M.
    Zhonghua Wai Ke Za Zhi; 2008 May 01; 46(9):670-3. PubMed ID: 18956719
    [Abstract] [Full Text] [Related]

  • 18. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S, Kwok Y, Krasna M, Bangalore M, Suntharalingam M.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1438-43. PubMed ID: 16029805
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 20. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.
    Hatoum HA, Jamali FR, El-Saghir NS, Musallam KM, Seoud M, Dimassi H, Abbas J, Khalife M, Boulos FI, Tawil AN, Geara FB, Salem Z, Shamseddine AA, Al-Feghali K, Shamseddine AI.
    Ann Surg Oncol; 2009 Dec 12; 16(12):3388-95. PubMed ID: 19655200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.